Nothing Special   »   [go: up one dir, main page]

Zhu et al., 2023 - Google Patents

FOXP2 confers oncogenic effects in prostate cancer

Zhu et al., 2023

View PDF
Document ID
11072884144778016386
Author
Zhu X
Chen C
Wei D
Xu Y
Liang S
Jia W
Li J
Qu Y
Zhai J
Zhang Y
Wu P
Hao Q
Zhang L
Zhang W
Yang X
Pan L
Qi R
Li Y
Wang F
Yi R
Yang Z
Wang J
Zhao Y
Publication year
Publication venue
Elife

External Links

Snippet

Identification oncogenes is fundamental to revealing the molecular basis of cancer. Here, we found that FOXP2 is overexpressed in human prostate cancer cells and prostate tumors, but its expression is absent in normal prostate epithelial cells and low in benign prostatic …
Continue reading at elifesciences.org (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Similar Documents

Publication Publication Date Title
Stringer et al. A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
Yang et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway
Zingg et al. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Zhou et al. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer
Whissell et al. The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression
Compagno et al. Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells
Lin et al. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival
Veeraraghavan et al. Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project Wu Gang 1 Diaz Alexander K 2 3 Paugh Barbara S 2 Rankin Sherri L 2 Ju Bensheng 4 Li Yongjin 1 Zhu Xiaoyan 2 Qu Chunxu 1 Chen Xiang 1 Zhang Junyuan 2 Easton John 5 Edmonson Michael 1 Ma Xiaotu 1 Lu Charles 6 Nagahawatte Panduka 1 Hedlund Erin 1 Rusch Michael 1 Pounds Stanley 7 Lin Tong 7 Onar-Thomas Arzu 7 http://orcid. org/0000-0001-7077-7470 Huether Robert 1 Kriwacki Richard 8 Parker Matthew 1 Gupta Pankaj 1 Becksfort Jared 1 Wei Lei 9 Mulder Heather L 5 Boggs Kristy 5 Vadodaria Bhavin 5 Yergeau Donald 5 Russell Jake C 2 Ochoa Kerri 6 Fulton Robert S 6 Fulton Lucinda L 6 Jones Chris 10 11 Boop Frederick A 12 Broniscer Alberto 13 Wetmore Cynthia 13 Gajjar Amar 13 Ding Li 6 Mardis Elaine R 6 Wilson Richard K 6 Taylor Michael R 4 Downing James R 14 Ellison David W 14 Zhang Jinghui jinghui. zhang@ stjude. org 1 ba Baker Suzanne J suzanne. baker@ stjude. org 2 3 bb The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Wu et al. Identification of targetable FGFR gene fusions in diverse cancers
Robinson et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Zhang et al. Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases
Rahrmann et al. Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen
Wu et al. Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
Oh et al. Alterations in the NF2/LATS1/LATS2/YAP pathway in schwannomas
Kim et al. H3K9 methyltransferase G9a negatively regulates UHRF1 transcription during leukemia cell differentiation
Zhong et al. Circular RNA encoded MET variant promotes glioblastoma tumorigenesis
Guan et al. FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer
Zhu et al. FOXP2 confers oncogenic effects in prostate cancer
Zhu et al. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5
Shi et al. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA
Gong et al. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis
Annala et al. Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
Hsieh et al. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors
Rebolledo-Jaramillo et al. Teneurins: an integrative molecular, functional, and biomedical overview of their role in cancer